🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/11/2007 | 48,78 | 49,69 | 48,20 | 49,23 | +0,73% | 3,05% | 1.202.000 |
| 19/11/2007 | 49,73 | 50,96 | 48,77 | 48,88 | -2,24% | 4,41% | 2.299.000 |
| 16/11/2007 | 50,99 | 51,64 | 49,67 | 50,00 | -2,25% | 3,86% | 1.794.200 |
| 15/11/2007 | 51,88 | 52,24 | 50,52 | 51,15 | -1,42% | 3,33% | 797.000 |
| 14/11/2007 | 52,51 | 52,99 | 51,50 | 51,88 | -0,73% | 2,83% | 1.212.600 |
| 13/11/2007 | 51,88 | 52,64 | 51,77 | 52,26 | +1,89% | 1,68% | 1.082.000 |
| 12/11/2007 | 51,18 | 52,62 | 51,06 | 51,29 | +0,30% | 3,05% | 874.400 |
| 09/11/2007 | 50,01 | 51,71 | 50,00 | 51,14 | -0,36% | 3,42% | 1.330.200 |
| 08/11/2007 | 51,82 | 52,65 | 48,53 | 51,32 | -0,37% | 7,96% | 2.213.400 |
| 07/11/2007 | 50,34 | 52,48 | 50,29 | 51,51 | +0,03% | 4,35% | 2.032.000 |
| 06/11/2007 | 53,50 | 53,52 | 49,03 | 51,50 | -4,92% | 8,40% | 4.523.200 |
| 05/11/2007 | 52,43 | 55,00 | 52,27 | 54,16 | +5,32% | 5,22% | 6.163.600 |
| 02/11/2007 | 48,50 | 53,00 | 47,53 | 51,43 | +9,29% | 11,28% | 8.444.600 |
| 01/11/2007 | 44,87 | 48,37 | 44,40 | 47,06 | +37,51% | 8,86% | 29.067.800 |
| 31/10/2007 | 34,80 | 34,80 | 33,86 | 34,22 | -1,00% | 2,70% | 1.239.200 |
| 30/10/2007 | 35,62 | 35,66 | 34,46 | 34,57 | -3,29% | 3,37% | 1.248.200 |
| 29/10/2007 | 36,76 | 36,87 | 35,45 | 35,74 | -2,72% | 3,85% | 2.236.400 |
| 26/10/2007 | 36,27 | 36,77 | 35,85 | 36,74 | +1,58% | 2,54% | 615.000 |
| 25/10/2007 | 36,07 | 36,25 | 35,46 | 36,17 | +0,28% | 2,18% | 798.600 |
| 24/10/2007 | 36,03 | 36,90 | 35,55 | 36,07 | -0,18% | 3,76% | 1.398.000 |
| 23/10/2007 | 36,24 | 36,24 | 35,83 | 36,14 | +0,54% | 1,15% | 1.214.000 |
| 22/10/2007 | 35,45 | 36,15 | 35,40 | 35,94 | +1,50% | 2,12% | 1.683.600 |
| 19/10/2007 | 35,53 | 35,81 | 35,20 | 35,41 | -0,32% | 1,70% | 1.262.600 |
| 18/10/2007 | 35,00 | 35,55 | 34,84 | 35,53 | +0,91% | 2,03% | 1.202.800 |
| 17/10/2007 | 34,27 | 35,29 | 34,23 | 35,21 | +4,05% | 3,09% | 2.028.200 |
| 16/10/2007 | 32,95 | 33,95 | 32,95 | 33,84 | +2,61% | 3,04% | 1.164.800 |
| 15/10/2007 | 32,98 | 33,32 | 32,64 | 32,98 | -0,14% | 2,06% | 976.200 |
| 12/10/2007 | 32,79 | 33,08 | 32,52 | 33,02 | +0,70% | 1,71% | 728.000 |
| 11/10/2007 | 33,34 | 33,49 | 32,69 | 32,79 | -1,23% | 2,41% | 767.400 |
| 10/10/2007 | 33,44 | 33,71 | 33,09 | 33,20 | -0,75% | 1,85% | 967.800 |